The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Bill Owens, executive producer of television’s most popular and influential newsmagazine since 2019, said in a note to staff that it has “become clear that I would not be allowed to run the ...

If you have space for a real home library, how lucky for you! If not, do yourself a favor and get a reading tablet. You'll miss out on the tactile joy of reading, but they make building out a ...

Some of the world’s leading rice-producing countries are sitting on a vast belt of pollution caused by heavy metal, according to a new study that has raised urgent concerns about global food ...

and oil producers - under pressure from the United States - and an amendment to the federal budget law, they have yet to reach a final agreement, costing billions in lost revenue. The Kurdistan ...

Chris Hughes and JoJo Siwa's close relationship has been a huge talking point in this series of Celebrity Big Brother - and in tonight's episode the pair take their antics one step further. The ...

In a recent chat, Macjob, who is an Emmy nominee, senior journalist and producer with the British Broadcasting Corporation, explained the resolve to tell a slave story that many believe has been ...

This contrasts with the currently approved oral GLP-1 RA semaglutide (Rybelsus, Novo Nordisk), a peptide which ideally should be taken fasting and with no food or water for at least 30 minutes ...

Italian food producers worry that tariffs may price them out of the American market amid competition from U.S. goods that look and sound as if they are from Italy. Wheels of Grana Padano aging ...

New Delhi: In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE) studies conducted in USA and Canada, the Subject Expert ...

Conversely, Lilly's stock price jumped about 14.5% to $840. “While Novo had the headstart with approval of semaglutide, we believe that this first mover advantage has waned, with Lilly's ...